Executive Indian

Profiles of the operators building at scale

Twenty Months in Akron, Then Two Billion Dollars

Hemant Taneja's General Catalyst bought a hospital system to prove a thesis. Eleven months after closing, he led $2.0 billion into the power business behind AI.

New York Stock Exchange — Arild Vågen, CC BY-SA 4.0, via Wikimedia Commons
New York Stock Exchange — Arild Vågen, CC BY-SA 4.0, via Wikimedia Commons

On October 2, 2026, a Delaware limited partnership called GC Venture XIII (ASI), L.P. agreed to buy 200,000 preferred shares at $10,000 apiece. The seller was Axiom Solutions International, the cloud and power infrastructure business that Flex intends to spin out as a public company in the first quarter of 2027. The price was $2.0 billion. The implied starting enterprise value was $37.5 billion.

The lead buyer was General Catalyst, alongside Koch Equity Development and co-investors, and the name on the announcement was Hemant Taneja, its chief executive officer.

Venture firms do not usually put money of that size into a subsidiary of a Nasdaq-listed manufacturer. The structure explains why this one did. The preferred stock pays a 10.0 percent cash dividend until the separation, then steps down to 6.0 percent in cash or 7.0 percent paid in kind. If the spin-off is not consummated by December 31, 2027, Flex has guaranteed to redeem the shares at 115 percent of the purchase price in cash, or 125 percent in Flex shares. Any unpaid redemption carries 12 percent interest. General Catalyst also won the right to nominate one director to Axiom's board once the separation is complete.

"Axiom sits at the center of the power and infrastructure buildout that AI demands, and we’ve been impressed by the team’s execution and the scale of the opportunity ahead," Taneja said in the announcement.

The money went in at a moment when the question of whether any of this spending will pay is being asked out loud. Taneja had already answered it, in his own way, eleven months earlier.

Bubbles Are Good, He Said

Asked by TIME in November 2025 whether artificial intelligence was in a bubble, Taneja did not hedge. "First of all, bubbles are good. They organize capital and talent into a space that's interesting. Good outcomes do come out of that, even though you also see carnage."

He went further. The investment flowing into AI "will not make any sense if you try to recoup that investment in the context of cloud and software infrastructure," he said. It only made sense, in his telling, against the budgets that currently go to labour.

That is the thesis behind the Axiom money: the spend is justified by what it replaces, not by what it resembles. Flex says the proceeds will fund part of Axiom's pending acquisition of EPC Power, repay any bridge financing and pay the preferred dividends.

It is also the thesis of a man who has spent the past three years turning a venture capital firm into something closer to an owner, and discovering how slowly ownership arrives.

A Hospital As The Proof

On January 17, 2024, Summa Health in Akron, Ohio announced a non-binding letter of intent to be acquired by General Catalyst's Health Assurance Transformation Company, HATCo, which Taneja founded and chairs. "Our shared vision is to create a replicable healthcare model that marks a true and meaningful shift from a ‘sick care’ system to a resilient, proactive model of health assurance," he said that day.

The same day, Taneja and HATCo's chief executive, Marc Harrison, published an essay on General Catalyst's site that anticipated the objection before anyone raised it. "We understand that this may be mischaracterized as another ‘private equity’ deal."

The definitive agreement did not arrive until November 7, 2024. Its terms put numbers on the promise: a purchase price of $485 million, which with Summa's own cash would eliminate $850 million of existing debt; a commitment of $350 million in capital funding over five years; a further $200 million for transformation over seven. Applications went to the Ohio Attorney General, the Ohio Department of Insurance and the Federal Trade Commission.

Closing came on October 1, 2025, more than twenty months after the letter of intent. Summa, with more than 8,500 employees, passed into the ownership of a venture firm, with the transition to a for-profit, taxable structure listed among the first tasks. "We are making a generational investment in community health infrastructure. Our partnership with Summa in Akron will serve as a blueprint for the healthcare industry," Taneja said.

Twenty months is the complication. A firm whose chief executive prizes being intense and urgent in the short term spent the better part of two years inside a regulatory process to buy one health system, and the deal it closed was explicitly the stabilization phase, with transformation to follow. The following month Taneja told TIME: "We just closed on the acquisition of a health system in Akron, Ohio. And we're going to try to create that blueprint ourselves with our founders." The blueprint, by his own account, was still to be drawn.

Delhi, Then A Basement In Boston

Taneja has described where the long-horizon temperament comes from. At Stanford Graduate School of Business in 2024, he said: "I grew up in a low income household in Delhi and my parents taught me to be carefree." The family moved to Boston around 1989 or 1990 so the children could get an education, he said. His father had moved a year ahead to find a job, and lost it days after the rest of the family arrived. The first planning session for life in a new country, he recalled, took place in the basement of the house they were living in.

He collected five degrees at MIT, then left in 1999 with friends to start a mobile-computing company. Mobile was early. The business was sold a couple of years later, by his account, and Taneja arrived at General Catalyst as an entrepreneur in residence. The firm he now runs backs, in his words, "600 plus companies in our portfolio." The consequence, as he put it, is that "at any given moment, somebody is doing great and somebody’s in a really bad spot."

His method for living with that is almost actuarial. "I always just think about the worst case scenarios and the worst case scenarios are never really that bad."

The Coupon And The Clock

The Axiom structure is that method expressed as a term sheet. General Catalyst is paid 10 percent in cash to wait for a spin-off it does not control, with a guaranteed exit at a premium if the spin-off fails and a board seat if it succeeds. It is an owner's ambition wrapped in a lender's protections.

That is consistent with what Taneja told Stanford about why the firm rewrote its own process. "Yeah, talk is cheap," he said, explaining why every General Catalyst investment is now reviewed by a head of responsible innovation, a standard the firm imposed on itself and must now meet.

Two clocks are running. Flex says the Axiom separation is expected in the first quarter of 2027; the redemption guarantee expires at the end of that year. In Akron, the stabilization period that began on October 1, 2025 has no published end date.

Taneja's own closing advice to TIME reads like an instruction to himself. "My most important advice is this is peak ambiguity." The $2.0 billion is what he decided to do inside it.

Sources

  1. U.S. SEC EDGAR - Flex Ltd. Form 8-K Exhibit 99.1 (PR Newswire release dated 2026-10-05)
  2. U.S. SEC EDGAR - Flex Ltd. Form 8-K, Item 1.01, event date 2026-10-02, filed 2026-10-05
  3. General Catalyst (company team page, first person)
  4. Stanford Graduate School of Business - View From The Top transcript, published 2024-09-04
  5. Stanford Graduate School of Business - View From The Top transcript, published 2024-09-04
  6. Stanford Graduate School of Business - View From The Top transcript, published 2024-09-04
  7. Stanford Graduate School of Business - View From The Top transcript, published 2024-09-04
  8. TIME - interview published 2025-11-23
  9. TIME - interview published 2025-11-23
  10. TIME - interview published 2025-11-23
  11. TIME - interview published 2025-11-23
  12. Summa Health press release, 2025-10-01
  13. Summa Health press release, 2024-11-07
  14. Summa Health press release, 2024-01-17
  15. General Catalyst - essay by Hemant Taneja and Marc Harrison M.D., 2024-01-17